1. Home
  2. BNTC vs NBY Comparison

BNTC vs NBY Comparison

Compare BNTC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$13.25

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.95

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
NBY
Founded
1995
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.4M
31.6M
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
BNTC
NBY
Price
$13.25
$1.95
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$27.67
N/A
AVG Volume (30 Days)
95.9K
764.8K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
80.94
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.57
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$0.43
52 Week High
$17.15
$19.95

Technical Indicators

Market Signals
Indicator
BNTC
NBY
Relative Strength Index (RSI) 71.97 57.82
Support Level $12.79 $1.01
Resistance Level $14.13 $2.52
Average True Range (ATR) 0.65 0.26
MACD 0.24 0.11
Stochastic Oscillator 99.86 96.45

Price Performance

Historical Comparison
BNTC
NBY

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: